Osteoporotic hip and vertebral fractures have most serious impact on quality of life

A study presented today at the European Congress on Osteoporosis and Osteoarthritis currently taking place in Valencia, Spain has found that the initial quality of life loss following an osteoporotic fracture is substantial, especially with regard to hip and vertebral fractures. The study found differences in quality of life loss between countries after correcting for other explanatory variables.

The quality of life (QoL) of patients who sustained a hip, wrist or vertebral fracture was examined for the four months following the fracture. The study is part of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS) which is an international patient-based study endorsed by the International Osteoporosis Foundation. ICUROS investigates the costs and health effects of osteoporotic fractures in women and men over the age of fifty. The aim is to gather better information regarding the burden of osteoporosis in the participating countries and worldwide. Currently, eleven countries are involved in ICUROS.

Involving 2,737 patients from nine countries, the study found that quality of life loss over four months was highest for hip fractures, followed by vertebral and wrist fractures. Interestingly, significant variations between countries were identified. Quality of life loss after hip fracture was greatest in Lithuania, followed by Italy, Russia and Mexico. Lower quality of life loss was experienced by hip fracture patients in Austria and Sweden. In all countries in which vertebral fractures were studied, patients who were hospitalized experienced more quality of life loss than those who were not hospitalized following vertebral fracture.

Source: International Osteoporosis Foundation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers identify key osteoporosis-related gene and develop new mouse model of the disease